KIOVIG 100 mg/ml Solution for Infusion 50ml Vial

As seen on leading e-commerce platforms like Nahdi Online, , and , KIOVIG 100 mg/ml Solution for Infusion is a highly purified preparation of human normal immunoglobulin (IgG) for intravenous administration. It is derived from human plasma and contains a broad spectrum of antibodies typically found in the healthy adult population. This medication is crucial for patients requiring immunoglobulin replacement therapy or immunomodulation.

Benefits of Use

• Effective in treating primary immunodeficiency syndromes (PID) with impaired antibody production.
• Used for immunomodulation in various autoimmune neurological disorders such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN).
• Indicated for Idiopathic Thrombocytopenic Purpura (ITP) in patients at high risk of bleeding or prior to surgery.
• Beneficial in Kawasaki disease, a systemic vasculitis primarily affecting children.
• Supports patients undergoing allogeneic bone marrow transplantation.

How to Use

KIOVIG is for intravenous administration only and should be administered by a healthcare professional in a clinical setting.

1. The dosage and infusion rate will be determined by your doctor based on your medical condition, body weight, and response to treatment.
2. Ensure the solution is clear or slightly opalescent and colorless to pale yellow. Do not use if the solution is turbid or has particulates.
3. Bring the solution to room temperature (20°C - 25°C) before administration.
4. The infusion should start at a slow rate and can be gradually increased if well-tolerated.
5. Strict aseptic technique must be maintained throughout the preparation and administration process.

Caution & Warnings

• Administer with caution in patients with a history of allergic reactions to human immunoglobulins.
• Monitor patients closely for signs of hypersensitivity reactions, especially during the initial infusion and when switching between different IVIG products.
• Patients with pre-existing renal impairment, diabetes mellitus, or at risk for thrombotic events should be closely monitored.
• Risk of aseptic meningitis syndrome (AMS), renal dysfunction, thrombotic events, and hemolytic anemia exists.
• Do not mix KIOVIG with other medicinal products.
• Ensure adequate hydration before administering KIOVIG to patients at risk for acute kidney injury.
• This product is derived from human plasma. While measures are in place to reduce pathogen transmission, the risk cannot be entirely eliminated.

Ingredients

Each ml of KIOVIG 100 mg/ml solution contains 100 mg of human normal immunoglobulin. The excipients include glycine and water for injections.

Product Details

• Brand: KIOVIG
• Manufacturer: Takeda
• Drug Type: Prescription Only Medicine (POM)
• Form: Solution for Infusion
• Strength: 100 mg/ml
• Package Size: 50ml Vial
• Storage: Refrigerated (2°C - 8°C)